| Trial ID: | L6006 |
| Source ID: | NCT01219400
|
| Associated Drug: |
Vildagliptin
|
| Title: |
Vildagliptin and the Glucagon Response to Hypoglycemia in Insulin-Treated Patients With Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes
|
| Interventions: |
DRUG: Vildagliptin
|
| Outcome Measures: |
Primary: Glucagon response to hypoglycemia, Change in glucagon from before hypoglycemia clamp until after 45 min, 45 min | Secondary: Catecholamine response to hypoglycemia, Change in catecholamines from before hypoglycemic clamp to 45 min, 45 min
|
| Sponsor/Collaborators: |
Sponsor: Lund University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
28
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: BASIC_SCIENCE
|
| Start Date: |
2012-01
|
| Completion Date: |
2013-12
|
| Results First Posted: |
|
| Last Update Posted: |
2014-09-30
|
| Locations: |
Lund University, Lund, 22184, Sweden
|
| URL: |
https://clinicaltrials.gov/show/NCT01219400
|
